TY - JOUR
T1 - Discovery of O6-benzyl glaziovianin A, a potent cytotoxic substance and a potent inhibitor of α,β-tubulin polymerization
AU - Hayakawa, Ichiro
AU - Shioda, Shuya
AU - Chinen, Takumi
AU - Hatanaka, Taisei
AU - Ebisu, Haruna
AU - Sakakura, Akira
AU - Usui, Takeo
AU - Kigoshi, Hideo
N1 - Funding Information:
This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas ‘Chemical Biology of Natural Products’ (Grant Numbers JP23102014 , JP23102013 ) and for Scientific Research (Grant Number JP16K07710 ) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT)/Japanese Society for the Promotion of Science (JSPS). I.H. thanks the Okayama Foundation for Science and Technology, Kurata Grant awarded by the Kurata Memorial Hitachi Science and Technology Foundation, the NOVARTIS Foundation (Japan) for the Promotion of Science, the Naito Foundation, and the Suzuken Memorial Foundation for their financial support. We would also like to thank Prof. Elmar Schiebel (Zentrum für Molekulare Biologie der Universität Heidelberg) for his helpful discussion.
Publisher Copyright:
© 2016 Elsevier Ltd
PY - 2016
Y1 - 2016
N2 - We have discovered O6-benzyl glaziovianin A, which showed stronger inhibition of microtubule polymerization (IC50 = 2.1 μM) than known α,β-tubulin inhibitors, such as colchicine and glaziovianin A. Also, we performed competition binding experiments of O6-benzyl glaziovianin A and revealed that O6-benzyl glaziovianin A binds to the colchicine binding site with high affinity. It is interesting that glaziovianin A derivatives change their mode of action in benzylation at the O6(α,β-tubulin inhibitor) or O7(γ-tubulin-specific inhibitor) position.
AB - We have discovered O6-benzyl glaziovianin A, which showed stronger inhibition of microtubule polymerization (IC50 = 2.1 μM) than known α,β-tubulin inhibitors, such as colchicine and glaziovianin A. Also, we performed competition binding experiments of O6-benzyl glaziovianin A and revealed that O6-benzyl glaziovianin A binds to the colchicine binding site with high affinity. It is interesting that glaziovianin A derivatives change their mode of action in benzylation at the O6(α,β-tubulin inhibitor) or O7(γ-tubulin-specific inhibitor) position.
KW - Cytotoxicity
KW - O-Benzyl glaziovianin A
KW - Structure–activity relationship study
KW - α,β-Tubulin inhibitor
UR - http://www.scopus.com/inward/record.url?scp=84991660763&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84991660763&partnerID=8YFLogxK
U2 - 10.1016/j.bmc.2016.09.026
DO - 10.1016/j.bmc.2016.09.026
M3 - Article
C2 - 27665177
AN - SCOPUS:84991660763
SN - 0968-0896
VL - 24
SP - 5639
EP - 5645
JO - Bioorganic and Medicinal Chemistry
JF - Bioorganic and Medicinal Chemistry
IS - 21
ER -